Methadone Dose Adjustment After 5-Day Interruption
This patient must be restarted at an initial induction dose of 20-30 mg (not exceeding 30 mg on day one), treating them as a new methadone induction, regardless of their previous 105 mg maintenance dose.
Critical Safety Principle
After 5 days without methadone, loss of tolerance must be assumed 1. The FDA labeling explicitly states: "Loss of tolerance should be considered in any patient who has not taken opioids for more than 5 days. Initial doses should be lower for patients whose tolerance is expected to be low at treatment entry" 1. This patient has crossed that critical 5-day threshold, making them vulnerable to overdose if resumed at their previous dose.
Reinduction Protocol
Day 1:
- Start with 20-30 mg methadone (maximum 30 mg total on first day)
- Administer under supervision when patient shows withdrawal symptoms but no signs of sedation or intoxication
- Wait 2-4 hours after initial dose to assess for peak effects
- May add 5-10 mg if withdrawal symptoms persist or reappear
- Total day 1 dose should not ordinarily exceed 40 mg 1
Days 2-7:
- Make cautious dose adjustments based on withdrawal symptom control at peak activity (2-4 hours post-dose)
- Deaths have occurred in early treatment due to cumulative effects of the first several days' dosing 1
- Remind patient that the dose will "hold" longer as tissue stores accumulate
- Methadone requires 3-5 days to reach steady-state plasma concentrations 1
Subsequent Weeks:
- Gradually titrate upward toward the previous maintenance dose of 105 mg
- Most patients achieve clinical stability at 80-120 mg/day 1
- Monitor closely for signs of oversedation or respiratory depression
Why Not Resume at 105 mg?
The FDA labeling warns that "deaths have been reported during conversion to methadone from chronic, high-dose treatment with other opioid agonists and during initiation of methadone treatment" 1. Even though this patient was previously stable on 105 mg, the 5-day gap has eliminated their tolerance. Methadone's long half-life (8-59 hours) and tissue accumulation properties mean that resuming at the full dose could lead to fatal respiratory depression as levels build over several days.
Common Pitfall to Avoid
Do not assume that previous tolerance persists after a 5-day gap. The incarceration context is irrelevant to the pharmacology—what matters is the duration of interruption. Research confirms that forced withdrawal during incarceration increases overdose risk upon release 2, making proper reinduction even more critical for this patient's safety.
Monitoring Requirements
- Supervise dosing during reinduction period
- Assess for withdrawal symptoms and sedation at 2-4 hours post-dose
- Watch for cumulative effects over the first week
- Have naloxone available
- Monitor respiratory status and level of consciousness